- Home
- TPH vs DYN Comparison
TPH vs DYN Comparison
Compare TPH & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- DYN
- Stock Information
- Founded
- TPH 2009
- DYN 1984
- Country
- TPH United States
- DYN United States
- Employees
- TPH N/A
- DYN N/A
- Industry
- TPH Homebuilding
- DYN Medicinal Chemicals and Botanical Products
- Sector
- TPH Consumer Discretionary
- DYN Health Care
- Exchange
- TPH Nasdaq
- DYN Nasdaq
- Market Cap
- TPH 2.9B
- DYN 2.6B
- IPO Year
- TPH N/A
- DYN 2020
- Fundamental
- Price
- TPH $31.94
- DYN $10.46
- Analyst Decision
- TPH Buy
- DYN Strong Buy
- Analyst Count
- TPH 5
- DYN 12
- Target Price
- TPH $43.00
- DYN $47.73
- AVG Volume (30 Days)
- TPH 1.1M
- DYN 1.7M
- Earning Date
- TPH 04-24-2025
- DYN 05-01-2025
- Dividend Yield
- TPH N/A
- DYN N/A
- EPS Growth
- TPH 40.00
- DYN N/A
- EPS
- TPH 4.83
- DYN N/A
- Revenue
- TPH $4,492,870,000.00
- DYN N/A
- Revenue This Year
- TPH N/A
- DYN N/A
- Revenue Next Year
- TPH $6.89
- DYN N/A
- P/E Ratio
- TPH $6.59
- DYN N/A
- Revenue Growth
- TPH 20.93
- DYN N/A
- 52 Week Low
- TPH $30.25
- DYN $9.96
- 52 Week High
- TPH $47.78
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- TPH 45.79
- DYN 32.32
- Support Level
- TPH $31.10
- DYN $10.72
- Resistance Level
- TPH $32.96
- DYN $12.00
- Average True Range (ATR)
- TPH 0.83
- DYN 0.69
- MACD
- TPH 0.19
- DYN 0.00
- Stochastic Oscillator
- TPH 49.26
- DYN 17.54
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.